相似文献
1
Gene Expression and DNA Methylation as Prognostic Markers in Metastatic Castration-Resistant Prostate Cancer: Analysis of Circulating Tumor Cells and Paired Plasma-Derived Exosomes.
Cancers (Basel). 2023 Nov 8;15(22):5325. doi: 10.3390/cancers15225325.
2
Prognostic Significance of Gene Expression and DNA Methylation Markers in Circulating Tumor Cells and Paired Plasma Derived Exosomes in Metastatic Castration Resistant Prostate Cancer.
Cancers (Basel). 2021 Feb 13;13(4):780. doi: 10.3390/cancers13040780.
3
Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer.
J Transl Med. 2023 Jan 21;21(1):40. doi: 10.1186/s12967-022-03860-3.
4
Comparative Analysis of Genomic Alterations across Castration Sensitive and Castration Resistant Prostate Cancer via Circulating Tumor DNA Sequencing.
J Urol. 2021 Feb;205(2):461-469. doi: 10.1097/JU.0000000000001363. Epub 2020 Sep 8.
5
The role of actinin-4 (ACTN4) in exosomes as a potential novel therapeutic target in castration-resistant prostate cancer.
Biochem Biophys Res Commun. 2020 Mar 12;523(3):588-594. doi: 10.1016/j.bbrc.2019.12.084. Epub 2020 Jan 12.
6
Transcriptomic analysis of plasma exosomes provides molecular information of response to cabazitaxel treatment in men with metastatic castration-resistant prostate cancer.
Prostate. 2023 Jul;83(10):950-961. doi: 10.1002/pros.24536. Epub 2023 Apr 19.
7
Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9/circMID1/miR-506-3p/MID1.
J Transl Med. 2022 Aug 2;20(1):346. doi: 10.1186/s12967-022-03494-5.
8
Dynamic Profiling of Exosomal microRNAs in Blood Plasma of Patients with Castration-Resistant Prostate Cancer.
Front Biosci (Schol Ed). 2022 May 23;14(2):15. doi: 10.31083/j.fbs1402015.
9
Presence of CD133-positive circulating tumor cells predicts worse progression-free survival in patients with metastatic castration-sensitive prostate cancer.
Int J Urol. 2022 May;29(5):383-389. doi: 10.1111/iju.14801. Epub 2022 Jan 31.
10
Targeting Castration-Resistant Prostate Cancer Using Mesenchymal Stem Cell Exosomes for Therapeutic MicroRNA-let-7c Delivery.
Front Biosci (Landmark Ed). 2022 Sep 6;27(9):256. doi: 10.31083/j.fbl2709256.
本文引用的文献
1
Liquid biopsies: the future of cancer early detection.
J Transl Med. 2023 Feb 11;21(1):118. doi: 10.1186/s12967-023-03960-8.
2
Cancer statistics, 2023.
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
3
Tumor-Derived Extracellular Vesicles: Multifunctional Entities in the Tumor Microenvironment.
Annu Rev Pathol. 2023 Jan 24;18:205-229. doi: 10.1146/annurev-pathmechdis-031521-022116. Epub 2022 Oct 6.
4
Circulating tumor cell isolation for cancer diagnosis and prognosis.
EBioMedicine. 2022 Sep;83:104237. doi: 10.1016/j.ebiom.2022.104237. Epub 2022 Aug 27.
5
Tumor-derived extracellular vesicles as messengers of natural products in cancer treatment.
Theranostics. 2022 Jan 16;12(4):1683-1714. doi: 10.7150/thno.67775. eCollection 2022.
6
Circulating tumor cells: biology and clinical significance.
Signal Transduct Target Ther. 2021 Nov 22;6(1):404. doi: 10.1038/s41392-021-00817-8.
7
Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Biomedicines. 2021 Sep 17;9(9):1247. doi: 10.3390/biomedicines9091247.
8
Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management.
Biomedicines. 2021 Sep 8;9(9):1179. doi: 10.3390/biomedicines9091179.
9
Consensus on the Treatment and Follow-Up for Metastatic Castration-Resistant Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).
JCO Glob Oncol. 2021 Apr;7:559-571. doi: 10.1200/GO.20.00511.
10
Prognostic Significance of Gene Expression and DNA Methylation Markers in Circulating Tumor Cells and Paired Plasma Derived Exosomes in Metastatic Castration Resistant Prostate Cancer.
Cancers (Basel). 2021 Feb 13;13(4):780. doi: 10.3390/cancers13040780.
Zotero 插件